Harvard-Led Breakthrough Brings Faster, Safer TB Treatments to the World
New options make TB treatment faster, safer, and more accessible. A major breakthrough in tuberculosis treatment has emerged: ...
Ibj.com1d
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Medscape1d
Investigative Treatments for Moderate to Severe Psoriasis Reviewed
Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...
The Lancet1d
Weight-loss medications: promoting health and not harm
In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...
Exploring irritable bowel syndrome: A common disorder with complex gut-brain interactions
Bowel movements, bloating, and other digestive issues may not be the easiest topics to discuss with your doctor, but having a ...
NeurAxis Has Crafted An Inflection Point
NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.
Hosted on MSN6d
Genetically tailored diets successfully treat patients with IBS
A groundbreaking study suggests that genetic variations in carbohydrate digestion enzymes could hold the key to personalized ...